CBSX3 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Antibodies

Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins produced by B cells that play a crucial role in the immune system. They are composed of two heavy chains and two light chains, each with variable and constant domains. The variable domains contain complementary determining regions (CDRs) that are responsible for antigen binding, while the constant domains interact with other components of the immune system .

Structure and Function of Antibodies

  • Variable Regions: These regions contain CDRs (CDR-1, CDR-2, and CDR-3) that are highly variable and responsible for antigen recognition. The CDRs are separated by framework regions (FRs) that form a β-sheet structure .

  • Constant Regions: The Fc region, located at the base of the Y-shaped structure, interacts with immune cells and complement proteins to mediate immune responses such as opsonization and cell lysis .

Types of Antibodies

  • Monoclonal Antibodies (mAbs): These are antibodies produced by a single clone of cells, ensuring uniformity in their antigen-binding sites. They are widely used in therapeutic applications, including cancer treatment .

  • Bispecific Antibodies: These antibodies can bind to two different antigens simultaneously, offering potential advantages in treating complex diseases by targeting multiple pathways .

Research and Therapeutic Applications

  • Monoclonal Antibodies in Cancer Treatment: mAbs like CM313 target specific antigens (e.g., CD38) and exhibit potent anti-tumor activity through mechanisms such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) .

  • Bispecific Antibodies: These are being explored for their ability to target multiple antigens, enhancing therapeutic efficacy in conditions like inflammatory and autoimmune diseases .

Data Table: Types of Antibodies and Their Applications

Type of AntibodyDescriptionApplications
Monoclonal Antibody (mAb)Uniform antigen-binding sitesCancer treatment, autoimmune diseases
Bispecific AntibodyTargets two antigens simultaneouslyInflammatory and autoimmune diseases
Heavy-Chain Antibody (HcAb)Lacks light chains, found in camelidsPotential therapeutic applications

References

  1. Understanding the Significance and Implications of Antibody Structure: A review discussing antibody structure and function .

  2. Preclinical Characterization of a Novel CD38-Targeting Monoclonal Antibody: Details the therapeutic potential of monoclonal antibodies in cancer treatment .

  3. Fully Humanized Bispecific Antibody for CXCR3 and CCR6: Explores the use of bispecific antibodies in treating inflammatory diseases .

  4. Antibody Structure: Overview of antibody structure and function .

  5. B Cell Genomics and Antibody Diversity: Discusses the genetic mechanisms behind antibody diversity .

  6. Chromobox Protein Homolog 3 (CBX3) in Tumors: Investigates the role of CBX3 in tumor development and immune function .

  7. Design and Production of Bispecific Antibodies: Reviews advances in bispecific antibody design and production .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
CBSX3 antibody; At5g10860 antibody; T30N20.130 antibody; CBS domain-containing protein CBSX3 antibody; mitochondrial antibody
Target Names
CBSX3
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G10860

STRING: 3702.AT5G10860.1

UniGene: At.28210

Subcellular Location
Mitochondrion.

Q&A

What is CBSX3 and why is it relevant for antibody development?

CBSX3 is a CBS domain-containing protein that functions primarily in plant mitochondria, where it activates o-type thioredoxin (Trx-o2). This protein-protein interaction plays a crucial role in regulating reactive oxygen species (ROS) generation through the mitochondrial electron transport chain (ETC), particularly through complex II (succinate dehydrogenase) .
The development of specific antibodies against CBSX3 is essential for studying its localization, interaction partners, and regulatory functions in plant development and stress responses. When generating antibodies, researchers should consider targeting unique epitopes that distinguish CBSX3 from other CBS domain-containing proteins to ensure specificity.

How does CBSX3 function in mitochondrial ROS regulation?

CBSX3 functions through a regulatory pathway involving the activation of Trx-o2, which subsequently interacts with SDH1, a subunit of ETC complex II . The knockdown of CBSX3 results in insufficient ROS accumulation, leading to deficient lignin deposition and anther indehiscence in plants. Conversely, overexpression of CBSX3 increases ROS accumulation while decreasing cell cycle-related gene expression, resulting in retarded plant growth and decreased leaf size .
When designing experiments with CBSX3 antibodies, researchers should consider:

  • Subcellular fractionation to confirm mitochondrial localization

  • Co-immunoprecipitation assays to verify interactions with Trx-o2 and SDH1

  • ROS detection assays in conjunction with immunostaining to correlate CBSX3 levels with ROS production

What are the typical applications for CBSX3 antibodies in plant research?

CBSX3 antibodies can be applied in multiple experimental contexts:

ApplicationMethodologyExpected Outcomes
Western BlottingProtein extraction from plant tissues, SDS-PAGE separation, transfer to membrane, and probing with CBSX3 antibodyDetection of CBSX3 protein levels in different tissues or under various stress conditions
ImmunoprecipitationCell lysate incubation with CBSX3 antibody, followed by protein A/G bead captureIsolation of CBSX3 complexes to identify interacting partners like Trx-o2
ImmunofluorescenceTissue fixation, permeabilization, blocking, and incubation with fluorophore-conjugated CBSX3 antibodyVisualization of CBSX3 subcellular localization
ChIP-seqChromatin crosslinking, fragmentation, and immunoprecipitation with CBSX3 antibody if it has DNA-binding capabilitiesIdentification of potential genomic binding sites

How should I select the appropriate CBSX3 antibody for my experimental needs?

When selecting a CBSX3 antibody, consider these critical factors:

  • Target species compatibility: Ensure the antibody recognizes CBSX3 from your model organism, as protein sequence conservation may vary across species.

  • Antibody type (monoclonal vs. polyclonal): Monoclonal antibodies offer high specificity for a single epitope, while polyclonal antibodies recognize multiple epitopes, providing stronger signals but potentially more cross-reactivity .

  • Application compatibility: Verify that the antibody has been validated for your specific application (WB, IP, IF, ELISA, etc.).

  • Epitope location: Consider whether the epitope is in a functional domain of CBSX3, such as the CBS domain or regions involved in protein-protein interactions.
    Methodologically, perform a bioinformatic analysis of CBSX3 protein sequences across different species to identify conserved regions for cross-species reactivity or unique regions for species-specific antibodies.

What validation methods should I employ to confirm CBSX3 antibody specificity?

Rigorous validation is essential to ensure experimental results are reliable. Implement these methodological approaches:

  • Positive and negative controls:

    • Use recombinant CBSX3 protein as a positive control

    • Include samples from CBSX3 knockout/knockdown plants as negative controls

    • Compare wild-type with CBSX3-overexpressing plants to verify signal intensity correlation

  • Specificity tests:

    • Conduct peptide competition assays

    • Test cross-reactivity with other CBS domain-containing proteins

    • Perform immunoblotting against recombinant CBSX family proteins

  • Multi-method validation:

    • Verify results across different detection methods (e.g., if using for Western blot, confirm with immunofluorescence)

    • Compare results from multiple antibodies targeting different CBSX3 epitopes

How can I troubleshoot non-specific binding of CBSX3 antibodies?

Non-specific binding is a common challenge. Address it methodologically:

  • Optimization of blocking conditions:

    • Test different blocking agents (BSA, milk, normal serum)

    • Adjust blocking time and temperature

    • Consider adding detergents like Tween-20 at various concentrations

  • Antibody dilution optimization:

    • Perform titration experiments to determine optimal concentration

    • Test longer incubation at lower concentrations versus shorter incubation at higher concentrations

  • Stringency adjustments:

    • Modify salt concentration in washing buffers

    • Adjust pH of buffers

    • Increase number and duration of wash steps

  • Pre-adsorption:

    • Incubate antibody with tissue/cell lysate from negative control samples before use

How can I design experiments to study CBSX3-mediated ROS regulation using antibodies?

To investigate CBSX3's role in ROS regulation, implement this methodological framework:

  • Correlative analysis of CBSX3 expression and ROS levels:

    • Use CBSX3 antibodies for immunoblotting or immunohistochemistry

    • In parallel, measure ROS using fluorescent probes (e.g., DCF-DA, MitoSOX)

    • Compare wild-type, CBSX3 knockdown, and overexpression lines

  • Protein-protein interaction studies:

    • Perform co-immunoprecipitation with CBSX3 antibodies to pull down Trx-o2 and SDH1

    • Use proximity ligation assays to visualize interactions in situ

    • Conduct FRET/BRET experiments with tagged proteins and validate with antibodies

  • Functional analysis:

    • Combine antibody-based protein detection with measurement of mitochondrial complex II activity

    • Correlate CBSX3 levels with physiological responses to ETC inhibitors

    • Analyze lignification patterns in relation to CBSX3 expression using histochemical staining and immunolocalization

What experimental approaches can reveal the role of CBSX3 in plant development?

Based on findings that CBSX3 affects plant growth and development , consider these methodological approaches:

  • Developmental stage analysis:

    • Use immunohistochemistry with CBSX3 antibodies to track protein expression across developmental stages

    • Correlate with phenotypic observations in wild-type and mutant plants

    • Analyze tissue-specific expression patterns, particularly in reproductive tissues

  • Cell cycle correlation:

    • Perform dual immunostaining with CBSX3 antibodies and cell cycle markers

    • Flow cytometry analysis of cell cycle distribution in conjunction with CBSX3 immunostaining

    • Time-course analysis of CBSX3 levels during cell division

  • Stress response studies:

    • Monitor CBSX3 levels using antibodies during various stress conditions

    • Correlate with ROS production and lignification patterns

    • Analyze downstream signaling events using phospho-specific antibodies against potential targets

How can I integrate CBSX3 antibody-based techniques with other methodologies for comprehensive analysis?

  • Combine antibody-based detection with transcriptomic analysis:

    • Correlate protein levels (detected by antibodies) with mRNA expression

    • Identify potential post-transcriptional regulation mechanisms

    • Analyze downstream effects on gene expression patterns

  • Integrate with metabolomic approaches:

    • Measure metabolites in the TCA cycle and ROS pathway

    • Correlate with CBSX3 protein levels detected by antibodies

    • Analyze the impact of CBSX3 manipulation on cellular energy status

  • Incorporate structural biology:

    • Use antibodies to purify native CBSX3 complexes for structural studies

    • Employ epitope mapping to identify functional domains

    • Validate structural predictions with site-directed mutagenesis and antibody binding assays

How can I develop specific antibodies that distinguish between CBSX3 and other CBS domain-containing proteins?

Developing highly specific antibodies requires careful epitope selection and validation:

  • Bioinformatic analysis for epitope selection:

    • Perform multiple sequence alignment of CBSX family proteins

    • Identify regions unique to CBSX3, particularly outside the conserved CBS domain

    • Consider hydrophilicity, surface accessibility, and secondary structure predictions

  • Advanced immunization strategies:

    • Use synthetic peptides corresponding to unique CBSX3 regions

    • Consider recombinant protein fragments expressing only unique regions

    • Implement negative selection approaches to remove cross-reactive antibodies

  • Sophisticated screening methods:

    • Develop ELISA panels with all CBSX family members for cross-reactivity testing

    • Implement phage display technology for antibody selection

    • Apply computational modeling to predict antibody-antigen interactions

What methods can I use to study post-translational modifications of CBSX3?

Post-translational modifications (PTMs) often regulate protein function. Investigate CBSX3 PTMs through:

  • Phosphorylation analysis:

    • Develop phospho-specific antibodies targeting predicted phosphorylation sites

    • Use phosphatase treatments as controls for specificity

    • Combine with mass spectrometry to identify modification sites

  • Redox modification studies:

    • Given CBSX3's role in redox regulation, investigate thiol modifications

    • Use antibodies against oxidized cysteine residues

    • Implement differential alkylation techniques combined with antibody detection

  • Other potential PTMs:

    • Investigate ubiquitination status using co-immunoprecipitation with ubiquitin antibodies

    • Assess SUMOylation using SUMO-specific antibodies

    • Analyze acetylation status through acetyl-lysine antibodies

How can I apply advanced imaging techniques with CBSX3 antibodies to study its subcellular dynamics?

Combining CBSX3 antibodies with cutting-edge imaging methods enables detailed subcellular analysis:

  • Super-resolution microscopy:

    • Apply STORM or PALM techniques with fluorophore-conjugated CBSX3 antibodies

    • Analyze co-localization with mitochondrial markers at nanoscale resolution

    • Track dynamic changes in CBSX3 distribution during stress responses

  • Live-cell imaging approaches:

    • Use cell-permeable antibody fragments or intrabodies

    • Combine with mitochondrial dyes and ROS indicators

    • Perform FRAP (Fluorescence Recovery After Photobleaching) to analyze protein mobility

  • Correlative light and electron microscopy (CLEM):

    • Label CBSX3 with antibodies conjugated to both fluorophores and gold particles

    • Visualize precise subcellular localization at ultrastructural level

    • Combine with immuno-EM techniques for high-resolution localization

How should I interpret contradictory results from different CBSX3 antibodies?

When faced with conflicting data, implement this methodological troubleshooting approach:

  • Epitope consideration:

    • Determine if antibodies target different regions of CBSX3

    • Assess potential epitope masking due to protein-protein interactions

    • Consider conformational versus linear epitopes

  • Validation reinforcement:

    • Reconfirm antibody specificity using knockout/knockdown controls

    • Perform peptide competition assays for each antibody

    • Evaluate antibody performance across multiple experimental conditions

  • Complementary approaches:

    • Use tagged CBSX3 constructs and tag-specific antibodies as alternative detection methods

    • Implement orthogonal techniques like mass spectrometry for protein identification

    • Consider mRNA analysis alongside protein detection to resolve discrepancies

What controls are essential when studying CBSX3 in complex experimental systems?

Robust controls ensure reliable interpretation of CBSX3 antibody-based experiments:

  • Genetic controls:

    • Include wild-type, CBSX3 knockdown, and overexpression samples

    • Use related CBS domain protein mutants to assess potential compensation mechanisms

    • Consider inducible expression systems for temporal control studies

  • Biochemical controls:

    • Include recombinant CBSX3 protein standards

    • Perform antibody pre-absorption with immunizing peptide

    • Use isotype controls for immunoprecipitation and immunofluorescence

  • Experimental design controls:

    • Implement biological and technical replicates

    • Include time-course analyses for dynamic processes

    • Utilize multiple antibody concentrations to ensure detection is in the linear range

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.